]>
IRCT20171211037832N1 IRCT 2018-06-01 Yazd University of Medical Sciences The effect of traditional medicine COLIT RELIF in patients with ulcerative colitis THE EFFECT OF IRANIAN TRADITIONAL MEDICINE PRODUCT(COLIT RELIEF) IN PREVENTION THE RELAPSE OF ULCERATIVE COLITIS PAITIENT 2016-12-27 anticipated 40 Complete https://irct.ir/trial/28189 interventional Randomization: Randomized, Blinding: Triple blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: The research is experimental and experimental for 10 weeks for each patient. Patients were randomly assigned to two groups of 19 patients and 21 subjects divided into two groups: TAPERING, prednisolone 10 mg starting with 10 mg Sulfasalazine They also receive 2.5 to 3 grams per day. Our control group, along with its routine, received placebo in a 250 mg capsule once a day, and in the intervention group, traditional medicine COLIT RELIF was added to the patient's drug regimen in the form of a 250 mg capsule once a day, Blinding description: The present study is three-blind. This blindness was done by the patient, the pharmacist, and the person who analyzed the data. N/A Ulcerative colitis. Intervention 1: Intervention group: Intervention group: The product of traditional medicine COLIT RELIF is presented in the form of a 250 mg capsule once a day along with food and also prednisolone starting at a dose of 10 mg plus sulfasalazine with a dose of 2.5 to 3 grams per day. Intervention 2: Control group: Control group: Placebo in the form of a 250 mg capsule once a day as well as prednisolone started at a dose of 10 mg plus sulfasalazine with a dose of 2.5 to 3 grams per day. Yes - There is a plan to make this available What will be shared: The collected data includes a small fraction of the demographic characteristics and the mean clinical stability score. After being blinded, the analyst gets it. When: Get started two years after the results are published To whom: Researchers in the field of traditional medicine Conditions: If comparing the doses of the drug between the intervention and the control, or comparing the quality of the data with the new data. Where to obtain: Faculty of Ardakan Traditional Medicine How to obtain: In coordination with the Research Council and the Research and Student Vice-Chancellor of the Faculty of Traditional Medicine, Ardakan Branch, and after passing through its legal procedures. Comments:
public Majid Emtiazy
Faculty of Traditional Medicine, Imam Khomeini street, Ardakan
Ardakan Iran (Islamic Republic of) 8951737915 +98 35 2723 8917 dr.emtiazy@yahoo.com Yazd University of Medical Sciences scientific Majid Emtiazy
Traditional Medicine University, Imam Khomeini street, Ardakan
Ardakan Iran (Islamic Republic of) 8951737915 +98 35 2723 8917 dr.emtiazy@yahoo.com Yazd University of Medical Sciences Iran (Islamic Republic of) For patients, the diagnosis of infectious colitis is caused by Clostridium deficiency colitis, ischemic colitis, and drug dependent colitis. Patients with moderate to severe ulcerative colitis were diagnosed in the last month of the REMISSION phase. Failure to use other complementary and alternative therapies Completion of consent form in an informed manner no limit no limit Both Pregnancy or breastfeeding The creation of a drug complication or allergy Dissatisfaction with the continuation of treatment A06.1 K51.0Ulcerative (chronic) pancolitisbackwash ileitis Treatment - Drugs Treatment - Drugs Intervention group: Intervention group: The product of traditional medicine COLIT RELIF is presented in the form of a 250 mg capsule once a day along with food and also prednisolone starting at a dose of 10 mg plus sulfasalazine with a dose of 2.5 to 3 grams per day Control group: Control group: Placebo in the form of a 250 mg capsule once a day as well as prednisolone started at a dose of 10 mg plus sulfasalazine with a dose of 2.5 to 3 grams per day... The results of this study could be used to propose a new treatment protocol for ulcerative colitis. Timepoint: Effect of traditional medicine coliT relife before intervention and in weeks 2, 4, 6, 8 and 10 after intervention. Method of measurement: Regular medical check-ups. Proof of scientific validity and efficacy of traditional Iranian medicine in the treatment of ulcerative colitis. Timepoint: Before intervention and weeks 2, 4, and 6, 8 and 10 after intervention. Method of measurement: Regular patient visit and opinion form. Yazd University of Medical Sciences Approved 2016-12-26 Ethics Committee of Yazd University of Medical Sciences Central Organization of Yazd University of Medical Sciences. Shahid Bahonar Square yazd Yazd Iran (Islamic Republic of)